MILFORD, Mass. — Waters Corporation (NYSE:WAT) and BioCity, the UK’s largest bioscience incubator company, announced an agreement to launch an open access analytical laboratory. Located in the BioHub at Alderley Park, the laboratory will offer Waters’ state-of-the-art liquid chromatography (LC), mass spectrometry (MS) and informatics technologies, along with a suite of analytical platforms to scientists […]
MILFORD, Mass. — Waters Corporation (NYSE: WAT) today announced that the Waters® ACQUITY UPLC® I-Class IVD/Xevo® TQ-S micro IVD System is now manufactured as a U.S. FDA Class I medical device and is CE Marked to the European Directive 98/79/EC (IVDD). This development allows clinical laboratories to access leading innovations in liquid chromatography (LC) and […]
IRVINE, CALIF. – Mass Spec Lab, a privately-owned, leading-edge analytical business, announced the official company launch and new website. Mass Spec Lab was conceived to address difficult analytical and regulatory challenges in the biomedical device, pharmaceuticals and fine chemicals industries by applying state-of-the-art mass spectrometry (LC/MS/MS and GC/MS/MS) operated by seasoned post-doctorate level analytical scientists. […]
MILFORD, Mass. – Waters Corporation (NYSE:WAT) announced a new 24-sample option for its highly acclaimed GlycoWorks™ RapiFluor-MS™ N-Glycan Kit. The new format processes 24 samples – eight at a time – and opens the door further to laboratories that want to begin realizing the benefits that RapiFluor-MS brings to glycan analysis. Depending on a laboratory’s […]
SAN FRANCISCO — AGU 2015 – Scientists engaged in climate research, biochemistry, forensics and oil/gas exploration can analyze the isotopic anatomy of molecules using a new high-resolution isotope ratio mass spectrometer. It enables scientists to access the direct conditions under which molecules were formed, transported, stored and degraded. Thermo Fisher Scientific will showcase this and […]
SANTA CLARA – Agilent Technologies Inc. (NYSE: A) today announced that Dr. Jeffrey Gordon has received an Agilent Thought Leader Award in support of his pioneering research into the mutually beneficial relationship between the human body and the tens of trillions of microbes that inhabit the gastrointestinal tract. Dr. Gordon directs the Center for Genome […]
MORGANTOWN, W. Va. — Protea Biosciences Group, Inc. (OTCQB:PRGB) (“Protea”) announced today it is collaborating with Agilent Technologies, Inc. (NYSE:A) (“Agilent”), to address customer challenges within existing Biopharma bioanalytical workflows in order to meet the emerging needs of the growing biopharmaceutical industry. Under Terms of the Agreement, a Memorandum of Understanding (MOU), Protea, using Agilent […]
BALTIMORE, MD – University of Maryland (UM) Ventures and Pataigin, LLC, announced today that the University of Maryland, Baltimore (UMB) has granted Pataigin worldwide, exclusive licensing rights to UMB patents and technology to develop a method to quickly and accurately identify dangerous pathogens. Robert Ernst, Ph.D., associate professor of microbial pathogenesis at University of Maryland […]
St. Joseph, Mich–On October 20th LECO Corporation unveiled the new European Application and Technology Center in the Charlottenburg area of Berlin. This newly established facility is fully equipped with the latest LECO analytical technology in its applications lab, having close to 25 LECO instruments available for hands-on customer demonstrations and application work. The facility also […]
Cambridge, United Kingdom – At the annual meeting of the Metabolic Profiling Forum (MetaboMeeting 2015), Bruker today announced a new, integrated metabolomics solution, called MetaboScape®, which extends metabolomics data analysis for non-targeted experiments, based on metabolic pathway mapping. In the past decade, metabolomics has grown rapidly and has been widely adopted. The growing number of […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
